In the PyMT mammary tumor model, TAMs are phenotypically distinct from TRMs and are recruited from the bone marrow through tumor cell secretion of CSF-1 and the monocyte chemokine CCL2 (36, 101, 103). This evidence concerns the gene CSF1 and neoplasm.